Clinical Trial

LYT-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Study acronym: ELEVATE
Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This study a randomized, double-blind, four arm study to evaluate the safety and efficacy of LYT-100 compared to pirfenidone or placebo in adults with Idiopathic Pulmonary Fibrosis.
Protocol Amendment History 17 amendments
This ClinicalTrials.gov record has been amended 17 times since 2022-04-02; most recent amendment 2025-10-13.
Status change: Recruiting → Active, Not Recruiting 2024-05-06
Status change: Not Yet Recruiting → Recruiting 2022-08-17
Trial Details
NCT Number NCT05321420
Lead Sponsor PureTech
Conditions Idiopathic Pulmonary Fibrosis
Enrollment 240 participants
Start Date 2022-07-22
Primary Completion 2024-10-15 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-10-16